Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors

NCT02452710 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT02452710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02452710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2015
Completion date
February 1, 2017
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue in cancer survivors